Country websites:


The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

Not all products are cleared or available for sale in all Asia Pacific countries.

By clicking on the button "Accepted and Confirmed" you assure that you have taken note of this information and that you are a healthcare professional.



Safe and convenient for all

  • Patent-protected in-line closing
  • 50% less risk steps with stay•safe®
  • Guided operation
  • Free from breaking cones and clamps

Delivering CAPD therapy in a simple and convenient way with stay•safe®

Four steps to success

Designed for simplicity and convenience during operation, the stay•safe® system facilitates better patient compliance.
Patent-protected in-line closingThe unique PIN system automatically closes the catheter extension before disconnection. This minimises the possibility of related touch contamination.
50% less risk steps with stay•safe®PIN technology eliminates 1,460 risk steps* per patient year compared with conventional systems, thus contributing lower risk of contamination.
Guided operationThe control switch of the DISC guides patients through all essential steps of the procedure facilitating confidence and improved compliance.
Free from breaking cones and clampsWith the DISC your patients do not have to worry about clamping the wrong lines or forgetting where they are in the procedure.
stay•safe® system
PIN technology automatically closes the catheter extension, minimizing the possibility of related touch contamination.
Guided operation with the DISC.

*CAPD risk step analysis

Systemstay•safe©Other systems
Connections per day44
Disconnections per day04
Risk steps per year1,4602,920

Biofine® — Protecting your patients and the environment

Environmental life cycle — We know how to care for the environment

Environmental life cycle
Environmental life cycle

Related Content

1 Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL Kim YS, Ahn C, Kim MJ, and Shin SK. Superior patient survival for continous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation concentration (balance). Peritoneal Dialysis International 2005; 25(3):248-255.

2Lee YL, Choi HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL, Kim DJ, Kim YS, Kim MJ, and Shin SK. Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrology Dialysis Transplantation 2006;21:2893-2899.

3 Dunst R, Alscher DM, Knödler P, Pfinder-Nohe E, Tast C, Kuhlmann U, and Mettang T. Peritonitis rates using different CAPD systems. Peritoneal Dialysis International 2001;21(Suppl.2):S65

4 Van Biesen W, Kirchgessner J, Schilling H, Lage C, Lambert MC, Passilick-Deetjen J. stay•safe®, a new PVC-free system for PD: Results of the multicenter trial. Peritoneal Dialysis International 1999;19(Suppl.1):S43.

5 Lambert MC, Lage C, Kirchgessner J. stay•safe®, a new PVC-free system in long-term CAPD treatment. European Dialysis and Transplant Nurses Association/European Renal Care Association Journal 1999;25(3):30-34.

6 Issad B, Taamma R, Allouache M, Deray G. stay•safe®, a new PVC-free system for CAPD: Results of a multicenter survey. Peritoneal Dialysis International 2001;21(Suppl.1):S34.

7 Basile C, De Padova F, Giordano R, Montanaro A, De Maio P, Di Marco L, Ligorio VA, Semeraro A. The incidence of peritonitis declines after implementation of the stay•safe® system (sss). Blood Purification 2001;19:79.

8 Li PKT, Law MC, Chow KM, Chan WK, Szeto CC, Cheng YL, Wong TYH, Leung CB, Wang AYM, Lui SF, Yu AWY. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: A prospective, randomized, controlled, multicenter study. American Journal of Kidney Diseases 2002; Vol 40, No 2:373-380.